Autolus(AUTL) - 2024 Q3 - Quarterly Results

Financial Results - Autolus Therapeutics plc announced its financial results for Q3 2024, ending September 30, 2024[4]. - The financial results and corporate updates are not deemed "filed" under the Securities Exchange Act[4]. Corporate Updates - The company provided a corporate update during the conference call held on November 12, 2024[5]. - A press release detailing the financial results was issued, which is included as Exhibit 99.1[6]. - An updated corporate presentation was utilized during the conference call, available as Exhibit 99.2[5]. - The report was signed by CEO Christian Itin, Ph.D., on November 12, 2024[7]. Company Information - The company is listed on the Nasdaq Global Select Market under the trading symbol AUTL[2]. - The nominal value of the ordinary shares is $0.000042 per share[2]. - Autolus Therapeutics plc is not classified as an emerging growth company[3]. - The company is based in London, United Kingdom[1].